UBS Group’s Longevity Acquisition Corporation Ordinary Shares LOAC Stock Holding History

UBS Group’s Portfolio LOAC Stock Details LOAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-64	Closed	-$1K	–	9864
2020 Q4	$1K	Sell	64 -2,365	-97%	-$26K	﹤0.01%	8331
2020 Q3	$26K	Sell	2,429 -85	-3%	-$910	﹤0.01%	6117
2020 Q2	$27K	Buy	2,514 +2,214	+738%	+$23.4K	﹤0.01%	6363
2020 Q1	$3K	Hold	300	–	–	﹤0.01%	7564
2019 Q4	$3K	Hold	300	–	–	﹤0.01%	7794
2019 Q3	$3K	Buy	+300	New	+$3.06K	﹤0.01%	7695

UBS Group's LOAC Position: Q1 2021 in Review

UBS Group sold out of Longevity Acquisition Corporation Ordinary Shares (LOAC) in Q1 2021, closing a stake of 64 shares — an estimated $1K sold.

UBS Group first reported a position in LOAC in Q3 2019 and held it in 6 quarters. The position peaked at $27K in Q2 2020. 0 funds tracked by Wall St. Rank hold LOAC as of Q1 2021.

UBS Group reported no remaining Longevity Acquisition Corporation Ordinary Shares position as of Q1 2021 after selling out during the quarter.
UBS Group sold 64 Longevity Acquisition Corporation Ordinary Shares shares in Q1 2021, an estimated $1K.
UBS Group first reported a position in Longevity Acquisition Corporation Ordinary Shares in Q3 2019 and held it in 6 quarters.
UBS Group's Longevity Acquisition Corporation Ordinary Shares position peaked at $27K in Q2 2020.
0 funds tracked by Wall St. Rank held Longevity Acquisition Corporation Ordinary Shares as of Q1 2021.

Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.